Review





Similar Products

96
Vector Biolabs adenovirus
Adenovirus, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/Ad-m-CEBPB-shRNA/pm42888028-332-9-14
Average 96 stars, based on 1 article reviews
adenovirus - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
MedChemExpress cebpb sirna
Single‐cell expression profiling identifies and characterizes malignant epithelial clusters in BCa. (A) Schematic overview of the study design, illustrating the sampling and analytical workflow. (B, C) UMAP visualization of 178,633 cells derived from 24 samples, encompassing NAT, GC, Low_grade, and High_grade tissues, identifying seven major cell types. (D) Expression profiles of established markers across the designated cell clusters. (E) Box plots illustrating the proportions of the seven major cell types across different pathological stages. (F) Re‐clustering of epithelial cells revealing distinct heterogeneity across NAT, GC, Low_Grade, and High_Grade tissues. (G) CNV score highlighting genomic instability across epithelial subclusters. (H) Pathway enrichment scores in different epithelial cell clusters (labeled as g0, g1, etc.), as determined by GSVA. (I) Violin plots illustrating the upregulation of malignancy‐associated genes in epithelial cells during BCa progression. (J) Dot plots displaying the expression levels of malignancy‐associated genes across re‐clustered epithelial cell groups. (K) Pseudotime developmental trajectory of epithelial cells inferred using Monocle2 and CytoTRACE2. (L) Heatmap displaying the dynamic expression patterns of malignancy‐associated genes along the pseudotime trajectory. (M) Stemness scores for different epithelial cell clusters calculated with AddModuleScore. (N) GO enrichment analysis highlighting key biological processes associated with Cluster 1_SDC1. (O) Validation of SDC1 knockdown efficiency by Western blot and qRT‐PCR in UMUC3 cells transfected with control or SDC1 <t>siRNA.</t> (P) CCK8 assay assessing the effect of SDC1 knockdown on UMUC3 cell proliferation. (Q) Representative images of colony formation in UMUC3 cells after SDC1 knockdown, showing colony size. Scale bar = 100 μm. Statistical analysis of the colony formation assay is shown on the right ( n ≥ 10). (R) CellChat analysis illustrating altered intercellular signaling strengths received by epithelial cells in high‐grade tumors. Data are mean ± SD. Analyzed by Student's t ‐test (O, Q) or two‐way ANOVA with Dunnett's test (P). ** p < 0.01, *** p < 0.001 versus NC. BCa, bladder cancer; CCK8, Cell Counting Kit‐8; CNV, copy number variation; Comun. Prob., communication probability; GC, cystitis glandularis; GO, Gene Ontology; GSVA, Gene Set Variation Analysis; NAT, normal adjacent tissue; NC, negative control; pct.exp, percentage of expressed cells; qRT‐PCR, quantitative real‐time PCR; SDC1, syndecan 1; siRNA, small interfering RNA; UMAP, Uniform Manifold Approximation and Projection.
Cebpb Sirna, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/CEBP+beta+Antibody/pmc13674414-351-13-16
Average 94 stars, based on 1 article reviews
cebpb sirna - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Shanghai Genechem Ltd cebpb
Single‐cell expression profiling identifies and characterizes malignant epithelial clusters in BCa. (A) Schematic overview of the study design, illustrating the sampling and analytical workflow. (B, C) UMAP visualization of 178,633 cells derived from 24 samples, encompassing NAT, GC, Low_grade, and High_grade tissues, identifying seven major cell types. (D) Expression profiles of established markers across the designated cell clusters. (E) Box plots illustrating the proportions of the seven major cell types across different pathological stages. (F) Re‐clustering of epithelial cells revealing distinct heterogeneity across NAT, GC, Low_Grade, and High_Grade tissues. (G) CNV score highlighting genomic instability across epithelial subclusters. (H) Pathway enrichment scores in different epithelial cell clusters (labeled as g0, g1, etc.), as determined by GSVA. (I) Violin plots illustrating the upregulation of malignancy‐associated genes in epithelial cells during BCa progression. (J) Dot plots displaying the expression levels of malignancy‐associated genes across re‐clustered epithelial cell groups. (K) Pseudotime developmental trajectory of epithelial cells inferred using Monocle2 and CytoTRACE2. (L) Heatmap displaying the dynamic expression patterns of malignancy‐associated genes along the pseudotime trajectory. (M) Stemness scores for different epithelial cell clusters calculated with AddModuleScore. (N) GO enrichment analysis highlighting key biological processes associated with Cluster 1_SDC1. (O) Validation of SDC1 knockdown efficiency by Western blot and qRT‐PCR in UMUC3 cells transfected with control or SDC1 <t>siRNA.</t> (P) CCK8 assay assessing the effect of SDC1 knockdown on UMUC3 cell proliferation. (Q) Representative images of colony formation in UMUC3 cells after SDC1 knockdown, showing colony size. Scale bar = 100 μm. Statistical analysis of the colony formation assay is shown on the right ( n ≥ 10). (R) CellChat analysis illustrating altered intercellular signaling strengths received by epithelial cells in high‐grade tumors. Data are mean ± SD. Analyzed by Student's t ‐test (O, Q) or two‐way ANOVA with Dunnett's test (P). ** p < 0.01, *** p < 0.001 versus NC. BCa, bladder cancer; CCK8, Cell Counting Kit‐8; CNV, copy number variation; Comun. Prob., communication probability; GC, cystitis glandularis; GO, Gene Ontology; GSVA, Gene Set Variation Analysis; NAT, normal adjacent tissue; NC, negative control; pct.exp, percentage of expressed cells; qRT‐PCR, quantitative real‐time PCR; SDC1, syndecan 1; siRNA, small interfering RNA; UMAP, Uniform Manifold Approximation and Projection.
Cebpb, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/cebpb/pm41605306-216-8-17
Average 86 stars, based on 1 article reviews
cebpb - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology murine cebpb
Single‐cell expression profiling identifies and characterizes malignant epithelial clusters in BCa. (A) Schematic overview of the study design, illustrating the sampling and analytical workflow. (B, C) UMAP visualization of 178,633 cells derived from 24 samples, encompassing NAT, GC, Low_grade, and High_grade tissues, identifying seven major cell types. (D) Expression profiles of established markers across the designated cell clusters. (E) Box plots illustrating the proportions of the seven major cell types across different pathological stages. (F) Re‐clustering of epithelial cells revealing distinct heterogeneity across NAT, GC, Low_Grade, and High_Grade tissues. (G) CNV score highlighting genomic instability across epithelial subclusters. (H) Pathway enrichment scores in different epithelial cell clusters (labeled as g0, g1, etc.), as determined by GSVA. (I) Violin plots illustrating the upregulation of malignancy‐associated genes in epithelial cells during BCa progression. (J) Dot plots displaying the expression levels of malignancy‐associated genes across re‐clustered epithelial cell groups. (K) Pseudotime developmental trajectory of epithelial cells inferred using Monocle2 and CytoTRACE2. (L) Heatmap displaying the dynamic expression patterns of malignancy‐associated genes along the pseudotime trajectory. (M) Stemness scores for different epithelial cell clusters calculated with AddModuleScore. (N) GO enrichment analysis highlighting key biological processes associated with Cluster 1_SDC1. (O) Validation of SDC1 knockdown efficiency by Western blot and qRT‐PCR in UMUC3 cells transfected with control or SDC1 <t>siRNA.</t> (P) CCK8 assay assessing the effect of SDC1 knockdown on UMUC3 cell proliferation. (Q) Representative images of colony formation in UMUC3 cells after SDC1 knockdown, showing colony size. Scale bar = 100 μm. Statistical analysis of the colony formation assay is shown on the right ( n ≥ 10). (R) CellChat analysis illustrating altered intercellular signaling strengths received by epithelial cells in high‐grade tumors. Data are mean ± SD. Analyzed by Student's t ‐test (O, Q) or two‐way ANOVA with Dunnett's test (P). ** p < 0.01, *** p < 0.001 versus NC. BCa, bladder cancer; CCK8, Cell Counting Kit‐8; CNV, copy number variation; Comun. Prob., communication probability; GC, cystitis glandularis; GO, Gene Ontology; GSVA, Gene Set Variation Analysis; NAT, normal adjacent tissue; NC, negative control; pct.exp, percentage of expressed cells; qRT‐PCR, quantitative real‐time PCR; SDC1, syndecan 1; siRNA, small interfering RNA; UMAP, Uniform Manifold Approximation and Projection.
Murine Cebpb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/C%2FEBP+%CE%B2+siRNA/pmc12270669__mmc4-303-3-5
Average 93 stars, based on 1 article reviews
murine cebpb - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Thermo Fisher cebpb sirna
(A) Venn diagram of differentially expressed transcription factors from GEO/TCGA databases. (B-D) Heatmaps of 5 consistently dysregulated transcription factors (red: upregulated; green: downregulated). (E-G) <t>CEBPB</t> mRNA expression in different patient cohorts: UC patients (GSE87466: 21 healthy individuals vs 87 UC; Welch’s two-tailed t-test); CAC patients (GSE37283: 5 healthy individuals vs 11 CAC; unpaired t-test); and CRC patients (TCGA: 51 normal adjacent tumor (NAT) vs 383 tumors; Mann-Whitney U test). (H) Kaplan-Meier survival analysis of 376 CRC patients stratified by CEBPB mRNA expression (TCGA). Data are expressed as mean ± SD. *** P < 0.001.
Cebpb Sirna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/sirna+cebpb/bio_rxiv__2025__06__25__661448-31-14-17
Average 90 stars, based on 1 article reviews
cebpb sirna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biowit Technologies recombinant adeno-associated virus serotype 9 (raav9) expressing a sirna targeting cebpb (sicebpb)
<t>CEBPB</t> affects the progression of UCCRC mice: (a) the modeling method of AOM/DSS-induced UCCRC in mice and treatment regimens, (b) representative photographs of AOM/DSS-induced UCCRC in mice, (c) colorectal length of mice, (d) colon weight of mice, (e) survival rate of mice, and (f) body weight of mice. N = 10, * P < 0.05.
Recombinant Adeno Associated Virus Serotype 9 (Raav9) Expressing A Sirna Targeting Cebpb (Sicebpb), supplied by Biowit Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/raav9+flaga20/pmc12144910-40-8-23
Average 90 stars, based on 1 article reviews
recombinant adeno-associated virus serotype 9 (raav9) expressing a sirna targeting cebpb (sicebpb) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ribobio co sirna targeting cebpb
<t>CEBPB</t> affects the progression of UCCRC mice: (a) the modeling method of AOM/DSS-induced UCCRC in mice and treatment regimens, (b) representative photographs of AOM/DSS-induced UCCRC in mice, (c) colorectal length of mice, (d) colon weight of mice, (e) survival rate of mice, and (f) body weight of mice. N = 10, * P < 0.05.
Sirna Targeting Cebpb, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/si+ppar%CE%B2+%CE%B4/pm40461968-80-14-20
Average 90 stars, based on 1 article reviews
sirna targeting cebpb - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Vector Biolabs adenovirus ad shcebpb
<t>CEBPB</t> affects the progression of UCCRC mice: (a) the modeling method of AOM/DSS-induced UCCRC in mice and treatment regimens, (b) representative photographs of AOM/DSS-induced UCCRC in mice, (c) colorectal length of mice, (d) colon weight of mice, (e) survival rate of mice, and (f) body weight of mice. N = 10, * P < 0.05.
Adenovirus Ad Shcebpb, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpb+sirna/Ad-m-CEBPB-shRNA/pm39162082-307-10-13
Average 96 stars, based on 1 article reviews
adenovirus ad shcebpb - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


Single‐cell expression profiling identifies and characterizes malignant epithelial clusters in BCa. (A) Schematic overview of the study design, illustrating the sampling and analytical workflow. (B, C) UMAP visualization of 178,633 cells derived from 24 samples, encompassing NAT, GC, Low_grade, and High_grade tissues, identifying seven major cell types. (D) Expression profiles of established markers across the designated cell clusters. (E) Box plots illustrating the proportions of the seven major cell types across different pathological stages. (F) Re‐clustering of epithelial cells revealing distinct heterogeneity across NAT, GC, Low_Grade, and High_Grade tissues. (G) CNV score highlighting genomic instability across epithelial subclusters. (H) Pathway enrichment scores in different epithelial cell clusters (labeled as g0, g1, etc.), as determined by GSVA. (I) Violin plots illustrating the upregulation of malignancy‐associated genes in epithelial cells during BCa progression. (J) Dot plots displaying the expression levels of malignancy‐associated genes across re‐clustered epithelial cell groups. (K) Pseudotime developmental trajectory of epithelial cells inferred using Monocle2 and CytoTRACE2. (L) Heatmap displaying the dynamic expression patterns of malignancy‐associated genes along the pseudotime trajectory. (M) Stemness scores for different epithelial cell clusters calculated with AddModuleScore. (N) GO enrichment analysis highlighting key biological processes associated with Cluster 1_SDC1. (O) Validation of SDC1 knockdown efficiency by Western blot and qRT‐PCR in UMUC3 cells transfected with control or SDC1 siRNA. (P) CCK8 assay assessing the effect of SDC1 knockdown on UMUC3 cell proliferation. (Q) Representative images of colony formation in UMUC3 cells after SDC1 knockdown, showing colony size. Scale bar = 100 μm. Statistical analysis of the colony formation assay is shown on the right ( n ≥ 10). (R) CellChat analysis illustrating altered intercellular signaling strengths received by epithelial cells in high‐grade tumors. Data are mean ± SD. Analyzed by Student's t ‐test (O, Q) or two‐way ANOVA with Dunnett's test (P). ** p < 0.01, *** p < 0.001 versus NC. BCa, bladder cancer; CCK8, Cell Counting Kit‐8; CNV, copy number variation; Comun. Prob., communication probability; GC, cystitis glandularis; GO, Gene Ontology; GSVA, Gene Set Variation Analysis; NAT, normal adjacent tissue; NC, negative control; pct.exp, percentage of expressed cells; qRT‐PCR, quantitative real‐time PCR; SDC1, syndecan 1; siRNA, small interfering RNA; UMAP, Uniform Manifold Approximation and Projection.

Journal: iMetaOmics

Article Title: Integrin α5β1‐mediated multicellular crosstalk in the tumor microenvironment drives bladder cancer progression and reveals targetable vulnerabilities

doi: 10.1002/imo2.70102

Figure Lengend Snippet: Single‐cell expression profiling identifies and characterizes malignant epithelial clusters in BCa. (A) Schematic overview of the study design, illustrating the sampling and analytical workflow. (B, C) UMAP visualization of 178,633 cells derived from 24 samples, encompassing NAT, GC, Low_grade, and High_grade tissues, identifying seven major cell types. (D) Expression profiles of established markers across the designated cell clusters. (E) Box plots illustrating the proportions of the seven major cell types across different pathological stages. (F) Re‐clustering of epithelial cells revealing distinct heterogeneity across NAT, GC, Low_Grade, and High_Grade tissues. (G) CNV score highlighting genomic instability across epithelial subclusters. (H) Pathway enrichment scores in different epithelial cell clusters (labeled as g0, g1, etc.), as determined by GSVA. (I) Violin plots illustrating the upregulation of malignancy‐associated genes in epithelial cells during BCa progression. (J) Dot plots displaying the expression levels of malignancy‐associated genes across re‐clustered epithelial cell groups. (K) Pseudotime developmental trajectory of epithelial cells inferred using Monocle2 and CytoTRACE2. (L) Heatmap displaying the dynamic expression patterns of malignancy‐associated genes along the pseudotime trajectory. (M) Stemness scores for different epithelial cell clusters calculated with AddModuleScore. (N) GO enrichment analysis highlighting key biological processes associated with Cluster 1_SDC1. (O) Validation of SDC1 knockdown efficiency by Western blot and qRT‐PCR in UMUC3 cells transfected with control or SDC1 siRNA. (P) CCK8 assay assessing the effect of SDC1 knockdown on UMUC3 cell proliferation. (Q) Representative images of colony formation in UMUC3 cells after SDC1 knockdown, showing colony size. Scale bar = 100 μm. Statistical analysis of the colony formation assay is shown on the right ( n ≥ 10). (R) CellChat analysis illustrating altered intercellular signaling strengths received by epithelial cells in high‐grade tumors. Data are mean ± SD. Analyzed by Student's t ‐test (O, Q) or two‐way ANOVA with Dunnett's test (P). ** p < 0.01, *** p < 0.001 versus NC. BCa, bladder cancer; CCK8, Cell Counting Kit‐8; CNV, copy number variation; Comun. Prob., communication probability; GC, cystitis glandularis; GO, Gene Ontology; GSVA, Gene Set Variation Analysis; NAT, normal adjacent tissue; NC, negative control; pct.exp, percentage of expressed cells; qRT‐PCR, quantitative real‐time PCR; SDC1, syndecan 1; siRNA, small interfering RNA; UMAP, Uniform Manifold Approximation and Projection.

Article Snippet: Monocytic MDSCs (CD11b+CD33+HLA‐DR^low) were sorted by flow cytometry (BD Biosciences) and transfected with CEBPB siRNA (HY‐RS02446, MCE).

Techniques: Single Cell, Expressing, Profiling, Sampling, Derivative Assay, Labeling, Analysis, Biomarker Discovery, Knockdown, Western Blot, Quantitative RT-PCR, Transfection, Control, CCK-8 Assay, Colony Assay, Cell Counting, Tissue, Negative Control, Real-time Polymerase Chain Reaction, Small Interfering RNA

Transcriptional characterization and identification of myeloid‐derived suppressor cell (MDSC) subsets in high‐grade BCa. (A) UMAP plot illustrating the classification of myeloid cell subtypes. (B) Dot plots displaying the expression of common marker genes across each myeloid cell subset. (C) Bar plots illustrating the total cell numbers of each myeloid cell subset across various sample types. (D) Dot plots depicting Spearman correlation between CAFs and myeloid subtype infiltration in the TCGA‐BLCA cohort. The size of each dot is proportional to the absolute magnitude of the correlation coefficient, and the color intensity indicates the correlation value (red for positive, blue for negative). (E) Mountain plot illustrating the enrichment scores of selected Hallmark gene sets across different myeloid cell subtypes. (F) GO enrichment analysis highlighting BP and CC pathways based on highly variable genes in the Mono_TYMP subset. Bar length denotes enrichment significance (−log 10 p value), while the yellow line represents the percent of geneRatio. (G) Pseudotime trajectory inferring the developmental evolution of myeloid cells. (H) Expression profiles of immune suppression‐related molecules across different myeloid cell subtypes. (I) Estimation of M‐MDSC‐related gene set scores across myeloid cell subtypes using AddModuleScore. (J) M‐MDSC scoring in the tumor progression of LUAD ( GSE189357 ) and BCa. p values were calculated via two‐sided Wilcoxon rank‐sum test. (K) CellPhoneDB analysis of ligand–receptor interactions in coinhibitory signaling pathways between different myeloid cell subtypes and T/NK cells. (L) Bubble plot illustrating signaling pathway interactions from different myeloid cell subtypes to endothelial cells. (M) mIF staining visualizing the spatial proximity between NAMPT+ cells and ITGB1+ cells. Quantification is shown on the right. Data are presented as mean ± SD. p values were calculated via Student's t ‐test. Scale bar = 10 μm. (N) Representative mIF images showing colocalization of VEGF‐expressing MDSCs and endothelial cells (CD31). Scale bar = 10 μm. (O) Mountain plot showing the activity of the STAT3 and CEBPB regulons. (P) Regulatory network plot illustrating the transcription factors (STAT3 and CEBPB) and their target genes. Node size is proportional to the node degree (number of connections). Node and edge colors represent the specific transcription factor regulons (STAT3 network in red, CEBPB network in blue). (Q) Spearman correlation analysis showing the association between the expression of CEBPB and NAMPT , as well as the angiogenesis‐related gene RHOB , in the TCGA‐BLCA cohort. (R) Schematic diagram of the regulatory network. Black arrows indicate transcriptional activation of target genes by STAT3 and CEBPB. Red upward arrows denote the upregulation of these genes. * p < 0.05; ** p < 0.01; *** p < 0.001. BP, biological process; CC, cellular component; LUAD, lung adenocarcinoma; MDSC, myeloid‐derived suppressor cell; M‐MDSC, monocytic MDSC.

Journal: iMetaOmics

Article Title: Integrin α5β1‐mediated multicellular crosstalk in the tumor microenvironment drives bladder cancer progression and reveals targetable vulnerabilities

doi: 10.1002/imo2.70102

Figure Lengend Snippet: Transcriptional characterization and identification of myeloid‐derived suppressor cell (MDSC) subsets in high‐grade BCa. (A) UMAP plot illustrating the classification of myeloid cell subtypes. (B) Dot plots displaying the expression of common marker genes across each myeloid cell subset. (C) Bar plots illustrating the total cell numbers of each myeloid cell subset across various sample types. (D) Dot plots depicting Spearman correlation between CAFs and myeloid subtype infiltration in the TCGA‐BLCA cohort. The size of each dot is proportional to the absolute magnitude of the correlation coefficient, and the color intensity indicates the correlation value (red for positive, blue for negative). (E) Mountain plot illustrating the enrichment scores of selected Hallmark gene sets across different myeloid cell subtypes. (F) GO enrichment analysis highlighting BP and CC pathways based on highly variable genes in the Mono_TYMP subset. Bar length denotes enrichment significance (−log 10 p value), while the yellow line represents the percent of geneRatio. (G) Pseudotime trajectory inferring the developmental evolution of myeloid cells. (H) Expression profiles of immune suppression‐related molecules across different myeloid cell subtypes. (I) Estimation of M‐MDSC‐related gene set scores across myeloid cell subtypes using AddModuleScore. (J) M‐MDSC scoring in the tumor progression of LUAD ( GSE189357 ) and BCa. p values were calculated via two‐sided Wilcoxon rank‐sum test. (K) CellPhoneDB analysis of ligand–receptor interactions in coinhibitory signaling pathways between different myeloid cell subtypes and T/NK cells. (L) Bubble plot illustrating signaling pathway interactions from different myeloid cell subtypes to endothelial cells. (M) mIF staining visualizing the spatial proximity between NAMPT+ cells and ITGB1+ cells. Quantification is shown on the right. Data are presented as mean ± SD. p values were calculated via Student's t ‐test. Scale bar = 10 μm. (N) Representative mIF images showing colocalization of VEGF‐expressing MDSCs and endothelial cells (CD31). Scale bar = 10 μm. (O) Mountain plot showing the activity of the STAT3 and CEBPB regulons. (P) Regulatory network plot illustrating the transcription factors (STAT3 and CEBPB) and their target genes. Node size is proportional to the node degree (number of connections). Node and edge colors represent the specific transcription factor regulons (STAT3 network in red, CEBPB network in blue). (Q) Spearman correlation analysis showing the association between the expression of CEBPB and NAMPT , as well as the angiogenesis‐related gene RHOB , in the TCGA‐BLCA cohort. (R) Schematic diagram of the regulatory network. Black arrows indicate transcriptional activation of target genes by STAT3 and CEBPB. Red upward arrows denote the upregulation of these genes. * p < 0.05; ** p < 0.01; *** p < 0.001. BP, biological process; CC, cellular component; LUAD, lung adenocarcinoma; MDSC, myeloid‐derived suppressor cell; M‐MDSC, monocytic MDSC.

Article Snippet: Monocytic MDSCs (CD11b+CD33+HLA‐DR^low) were sorted by flow cytometry (BD Biosciences) and transfected with CEBPB siRNA (HY‐RS02446, MCE).

Techniques: Derivative Assay, Expressing, Marker, Analysis, Protein-Protein interactions, Staining, Activity Assay, Activation Assay

(A) Venn diagram of differentially expressed transcription factors from GEO/TCGA databases. (B-D) Heatmaps of 5 consistently dysregulated transcription factors (red: upregulated; green: downregulated). (E-G) CEBPB mRNA expression in different patient cohorts: UC patients (GSE87466: 21 healthy individuals vs 87 UC; Welch’s two-tailed t-test); CAC patients (GSE37283: 5 healthy individuals vs 11 CAC; unpaired t-test); and CRC patients (TCGA: 51 normal adjacent tumor (NAT) vs 383 tumors; Mann-Whitney U test). (H) Kaplan-Meier survival analysis of 376 CRC patients stratified by CEBPB mRNA expression (TCGA). Data are expressed as mean ± SD. *** P < 0.001.

Journal: bioRxiv

Article Title: Intestinal Epithelial C/EBPβ Deficiency Impairs Colitis-Associated Tumorigenesis by Disrupting CXCL1/CXCL2/CXCL5-CXCR2-Mediated Neutrophil Infiltration

doi: 10.1101/2025.06.25.661448

Figure Lengend Snippet: (A) Venn diagram of differentially expressed transcription factors from GEO/TCGA databases. (B-D) Heatmaps of 5 consistently dysregulated transcription factors (red: upregulated; green: downregulated). (E-G) CEBPB mRNA expression in different patient cohorts: UC patients (GSE87466: 21 healthy individuals vs 87 UC; Welch’s two-tailed t-test); CAC patients (GSE37283: 5 healthy individuals vs 11 CAC; unpaired t-test); and CRC patients (TCGA: 51 normal adjacent tumor (NAT) vs 383 tumors; Mann-Whitney U test). (H) Kaplan-Meier survival analysis of 376 CRC patients stratified by CEBPB mRNA expression (TCGA). Data are expressed as mean ± SD. *** P < 0.001.

Article Snippet: Reagents included AOM and SB225002 (Sigma, St. Louis, USA), DSS (MP Biomedicals, Solon, USA), CEBPB siRNA from Thermo Fisher (Grand Island, USA) (Supplementary Table S7), and a pcDNA3.1- CEBPB plasmid (Real Gene, Nanjing, China).

Techniques: Expressing, Two Tailed Test, MANN-WHITNEY

(A) Representative hematoxylin and eosin (H&E) and immunohistochemistry (IHC) staining of C/EBPβ in normal colon, CAC-adjacent (CAC-AT), and CAC tissues (100×: 100 μm scale; 400×: 25 μm scale). (B-C) Quantitative analysis of (B) C/EBPβ protein (IHC) and (C) C EBPB mRNA levels (normal: n = 10; CAC: n = 5; one-way ANOVA with Bonferroni correction). (D) CRC tissue microarrays (n = 180) showing C/EBPβ expression (40×: 250 μm scale; 200×: 50 μm scale). (E) C/EBPβ IHC scores across CRC Stages (Kruskal-Wallis with Dunn’s test). (F) Kaplan-Meier survival analysis of 180 CRC patients by C/EBPβ expression. (G-H) Western blot analyses of C/EBPβ expression in randomly selected CRC patients (n = 12). Protein levels were quantified by densitometry (normalized to GAPDH) using ImageJ software. Statistical analysis was conducted using the Mann-Whitney U test. (I) qRT-PCR was employed to evaluate CEBPB mRNA levels in randomly selected CRC patients (n = 64). Statistical analysis was performed using the Mann-Whitney U test. Data are expressed as mean ± SD. * P < 0.05, *** P < 0.001.

Journal: bioRxiv

Article Title: Intestinal Epithelial C/EBPβ Deficiency Impairs Colitis-Associated Tumorigenesis by Disrupting CXCL1/CXCL2/CXCL5-CXCR2-Mediated Neutrophil Infiltration

doi: 10.1101/2025.06.25.661448

Figure Lengend Snippet: (A) Representative hematoxylin and eosin (H&E) and immunohistochemistry (IHC) staining of C/EBPβ in normal colon, CAC-adjacent (CAC-AT), and CAC tissues (100×: 100 μm scale; 400×: 25 μm scale). (B-C) Quantitative analysis of (B) C/EBPβ protein (IHC) and (C) C EBPB mRNA levels (normal: n = 10; CAC: n = 5; one-way ANOVA with Bonferroni correction). (D) CRC tissue microarrays (n = 180) showing C/EBPβ expression (40×: 250 μm scale; 200×: 50 μm scale). (E) C/EBPβ IHC scores across CRC Stages (Kruskal-Wallis with Dunn’s test). (F) Kaplan-Meier survival analysis of 180 CRC patients by C/EBPβ expression. (G-H) Western blot analyses of C/EBPβ expression in randomly selected CRC patients (n = 12). Protein levels were quantified by densitometry (normalized to GAPDH) using ImageJ software. Statistical analysis was conducted using the Mann-Whitney U test. (I) qRT-PCR was employed to evaluate CEBPB mRNA levels in randomly selected CRC patients (n = 64). Statistical analysis was performed using the Mann-Whitney U test. Data are expressed as mean ± SD. * P < 0.05, *** P < 0.001.

Article Snippet: Reagents included AOM and SB225002 (Sigma, St. Louis, USA), DSS (MP Biomedicals, Solon, USA), CEBPB siRNA from Thermo Fisher (Grand Island, USA) (Supplementary Table S7), and a pcDNA3.1- CEBPB plasmid (Real Gene, Nanjing, China).

Techniques: Immunohistochemistry, Expressing, Western Blot, Software, MANN-WHITNEY, Quantitative RT-PCR

(A) Representative images of colons from untreated wild-type (WT) control mice and AOM/DSS-treated WT mice. (B) Cebpb mRNA levels in colonic tissue from WT control and AOM/DSS-treated WT mice were quantified by qRT-PCR. Statistical analysis was performed by Mann-Whitney U test; n = 5 mice/group. (C) Western blot analysis of C/EBPβ protein expression in colonic epithelium and stroma of WT control and AOM/DSS-treated WT mice. Protein levels were normalized to GAPDH. (D) Representative images of colons from three experimental groups: (i) WT control mice, (ii) AOM/DSS-treated WT mice (WT AOM/DSS), and (iii) AOM/DSS-treated mice with intestinal epithelial cell-specific Cebpb knockout ( Cebpb ΔIEC AOM/DSS). Tumor number and size were assessed; n = 5 mice/group. (E) Colon tumors were quantified by size stratification (>2 mm, measured by calipers; <2 mm, assessed by dissection microscope). Data were analyzed by one-way ANOVA with Bonferroni’s multiple comparisons test; n = 5 mice/group. (F) Representative H&E and IHC staining of C/EBPβ in colon tissues from WT control, WT AOM/DSS and Cebpb ΔIEC AOM/DSS mice. Scale bar = 100 μm. (G) Quantification of C/EBPβ-positive staining areas in colon tissues from WT control, WT AOM/DSS and Cebpb ΔIEC AOM/DSS mice by ImageJ software. (H-I) C/EBP β mRNA levels (qRT-PCR) and protein expression (Western blot) in colon tissues from WT control, WT AOM/DSS and Cebpb ΔIEC AOM/DSS mice. Statistical analysis was performed by Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 5 mice/group for qRT-PCR. Data are presented as mean ± SD. ns: not significant, * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: bioRxiv

Article Title: Intestinal Epithelial C/EBPβ Deficiency Impairs Colitis-Associated Tumorigenesis by Disrupting CXCL1/CXCL2/CXCL5-CXCR2-Mediated Neutrophil Infiltration

doi: 10.1101/2025.06.25.661448

Figure Lengend Snippet: (A) Representative images of colons from untreated wild-type (WT) control mice and AOM/DSS-treated WT mice. (B) Cebpb mRNA levels in colonic tissue from WT control and AOM/DSS-treated WT mice were quantified by qRT-PCR. Statistical analysis was performed by Mann-Whitney U test; n = 5 mice/group. (C) Western blot analysis of C/EBPβ protein expression in colonic epithelium and stroma of WT control and AOM/DSS-treated WT mice. Protein levels were normalized to GAPDH. (D) Representative images of colons from three experimental groups: (i) WT control mice, (ii) AOM/DSS-treated WT mice (WT AOM/DSS), and (iii) AOM/DSS-treated mice with intestinal epithelial cell-specific Cebpb knockout ( Cebpb ΔIEC AOM/DSS). Tumor number and size were assessed; n = 5 mice/group. (E) Colon tumors were quantified by size stratification (>2 mm, measured by calipers; <2 mm, assessed by dissection microscope). Data were analyzed by one-way ANOVA with Bonferroni’s multiple comparisons test; n = 5 mice/group. (F) Representative H&E and IHC staining of C/EBPβ in colon tissues from WT control, WT AOM/DSS and Cebpb ΔIEC AOM/DSS mice. Scale bar = 100 μm. (G) Quantification of C/EBPβ-positive staining areas in colon tissues from WT control, WT AOM/DSS and Cebpb ΔIEC AOM/DSS mice by ImageJ software. (H-I) C/EBP β mRNA levels (qRT-PCR) and protein expression (Western blot) in colon tissues from WT control, WT AOM/DSS and Cebpb ΔIEC AOM/DSS mice. Statistical analysis was performed by Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 5 mice/group for qRT-PCR. Data are presented as mean ± SD. ns: not significant, * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: Reagents included AOM and SB225002 (Sigma, St. Louis, USA), DSS (MP Biomedicals, Solon, USA), CEBPB siRNA from Thermo Fisher (Grand Island, USA) (Supplementary Table S7), and a pcDNA3.1- CEBPB plasmid (Real Gene, Nanjing, China).

Techniques: Control, Quantitative RT-PCR, MANN-WHITNEY, Western Blot, Expressing, Knock-Out, Dissection, Microscopy, Immunohistochemistry, Staining, Software

(A-C) Immune cell subsets in colon tissues from WT control, WT AOM/DSS, and Cebpb ΔIEC AOM/DSS mice were quantified by flow cytometry (n = 3 mice/group). Data analyzed by one-way ANOVA with Bonferroni’s correction. (D-I) Bioinformatics analysis of neutrophil-associated genes in human datasets (Mann-Whitney U test): For panels D-E, data were obtained from 26 healthy individuals and 11 CAC patients (GSE87466, GSE37283). For panels F-G, data were obtained from 41 normal adjacent tumor tissues (NAT) and 216 CRC samples (TCGA-COAD/READ). For panels H-I, data were collected from 21 healthy individuals and 87 UC patients (GSE87466 dataset). Data are expressed as mean ± SD. ns: not significant, * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: bioRxiv

Article Title: Intestinal Epithelial C/EBPβ Deficiency Impairs Colitis-Associated Tumorigenesis by Disrupting CXCL1/CXCL2/CXCL5-CXCR2-Mediated Neutrophil Infiltration

doi: 10.1101/2025.06.25.661448

Figure Lengend Snippet: (A-C) Immune cell subsets in colon tissues from WT control, WT AOM/DSS, and Cebpb ΔIEC AOM/DSS mice were quantified by flow cytometry (n = 3 mice/group). Data analyzed by one-way ANOVA with Bonferroni’s correction. (D-I) Bioinformatics analysis of neutrophil-associated genes in human datasets (Mann-Whitney U test): For panels D-E, data were obtained from 26 healthy individuals and 11 CAC patients (GSE87466, GSE37283). For panels F-G, data were obtained from 41 normal adjacent tumor tissues (NAT) and 216 CRC samples (TCGA-COAD/READ). For panels H-I, data were collected from 21 healthy individuals and 87 UC patients (GSE87466 dataset). Data are expressed as mean ± SD. ns: not significant, * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: Reagents included AOM and SB225002 (Sigma, St. Louis, USA), DSS (MP Biomedicals, Solon, USA), CEBPB siRNA from Thermo Fisher (Grand Island, USA) (Supplementary Table S7), and a pcDNA3.1- CEBPB plasmid (Real Gene, Nanjing, China).

Techniques: Control, Flow Cytometry, MANN-WHITNEY

(A-D) KEGG and gene set enrichment analysis (GSEA) of differentially expressed genes (DEGs) in colon tissues from WT control, WT AOM/DSS, and Cebpb ΔIEC AOM/DSS mice (n = 5 mice /group). (E-F) Heatmap showing 36 significantly enriched DEGs from the cytokine-cytokine receptor interaction pathway (Z-scores shown by color gradient). (G-H) CXCR2 ligand (CXCL1/2/5) and receptor levels in colon tissues measured by qRT-PCR (G; n = 5) and ELISA (H; n = 5. Statistical analysis was performed by one-way ANOVA with Bonferroni’s correction. (I-J) CXCL1/2/5 expression in Caco-2 cells with CEBPB overexpression (pcDNA3.1- CEBPB ) or knockdown ( CEBPB -siRNA), compared to their respective controls (one-way ANOVA with Bonferroni’s correction). (K) ChIP-qPCR confirming C/EBPβ binding to CXCL1/2/5 promoters (anti-C/EBPβ antibody vs. Input/IgG controls; unpaired t-test). (L) Luciferase reporter assays of CEBPB- responsive promoter activity (wild-type vs. mutant CXCL1/2/5 promoters) in CEBPB -overexpressing Caco-2 cells (unpaired t-test). (M-N) Representative images showing neutrophil migration toward supernatants from CEBPB -modulated Caco-2 cells (SB225002-pretreated; 100× magnification, scale bar = 100 μm; one-way ANOVA with Bonferroni’s correction) n = 3 biological replicates for panels I-N. Data are expressed as mean ± SD. ns: not significant, * P < 0.05, ** P < 0.01, *** P < 0.001.

Journal: bioRxiv

Article Title: Intestinal Epithelial C/EBPβ Deficiency Impairs Colitis-Associated Tumorigenesis by Disrupting CXCL1/CXCL2/CXCL5-CXCR2-Mediated Neutrophil Infiltration

doi: 10.1101/2025.06.25.661448

Figure Lengend Snippet: (A-D) KEGG and gene set enrichment analysis (GSEA) of differentially expressed genes (DEGs) in colon tissues from WT control, WT AOM/DSS, and Cebpb ΔIEC AOM/DSS mice (n = 5 mice /group). (E-F) Heatmap showing 36 significantly enriched DEGs from the cytokine-cytokine receptor interaction pathway (Z-scores shown by color gradient). (G-H) CXCR2 ligand (CXCL1/2/5) and receptor levels in colon tissues measured by qRT-PCR (G; n = 5) and ELISA (H; n = 5. Statistical analysis was performed by one-way ANOVA with Bonferroni’s correction. (I-J) CXCL1/2/5 expression in Caco-2 cells with CEBPB overexpression (pcDNA3.1- CEBPB ) or knockdown ( CEBPB -siRNA), compared to their respective controls (one-way ANOVA with Bonferroni’s correction). (K) ChIP-qPCR confirming C/EBPβ binding to CXCL1/2/5 promoters (anti-C/EBPβ antibody vs. Input/IgG controls; unpaired t-test). (L) Luciferase reporter assays of CEBPB- responsive promoter activity (wild-type vs. mutant CXCL1/2/5 promoters) in CEBPB -overexpressing Caco-2 cells (unpaired t-test). (M-N) Representative images showing neutrophil migration toward supernatants from CEBPB -modulated Caco-2 cells (SB225002-pretreated; 100× magnification, scale bar = 100 μm; one-way ANOVA with Bonferroni’s correction) n = 3 biological replicates for panels I-N. Data are expressed as mean ± SD. ns: not significant, * P < 0.05, ** P < 0.01, *** P < 0.001.

Article Snippet: Reagents included AOM and SB225002 (Sigma, St. Louis, USA), DSS (MP Biomedicals, Solon, USA), CEBPB siRNA from Thermo Fisher (Grand Island, USA) (Supplementary Table S7), and a pcDNA3.1- CEBPB plasmid (Real Gene, Nanjing, China).

Techniques: Control, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Expressing, Over Expression, Knockdown, ChIP-qPCR, Binding Assay, Luciferase, Activity Assay, Mutagenesis, Migration

(A) Colons specimens were harvested from four groups: (i) WT AOM/DSS, (ii) Cebpb ΔIEC AOM/DSS, and (iii-iv) SB225002 (CXCR2 antagonist)-treated counterparts (WT or Cebpb ΔIEC AOM/DSS mice). (B) Tumor burden quantification (>2 mm by calipers; <2 mm by dissection microscopy; one-way ANOVA with Bonferroni’s correction). n = 5 mice/group. (C) Representative H&E staining in colon tissues from four groups (100×, 100 μm scale). (D-E) Flow cytometry analysis of CD11b + Ly-6G + neutrophils among CD45 + leukocytes (one-way ANOVA with Bonferroni’s correction). (F-G) Immunofluorescence visualization (200×, 50 μm scale) and ImageJ quantification of Ly-6G + CD11b + cell infiltrate in 5 high-power fields (HPF). n = 5 mice/group. Data are expressed as mean ± SD. ns: not significant, *** P < 0.001.

Journal: bioRxiv

Article Title: Intestinal Epithelial C/EBPβ Deficiency Impairs Colitis-Associated Tumorigenesis by Disrupting CXCL1/CXCL2/CXCL5-CXCR2-Mediated Neutrophil Infiltration

doi: 10.1101/2025.06.25.661448

Figure Lengend Snippet: (A) Colons specimens were harvested from four groups: (i) WT AOM/DSS, (ii) Cebpb ΔIEC AOM/DSS, and (iii-iv) SB225002 (CXCR2 antagonist)-treated counterparts (WT or Cebpb ΔIEC AOM/DSS mice). (B) Tumor burden quantification (>2 mm by calipers; <2 mm by dissection microscopy; one-way ANOVA with Bonferroni’s correction). n = 5 mice/group. (C) Representative H&E staining in colon tissues from four groups (100×, 100 μm scale). (D-E) Flow cytometry analysis of CD11b + Ly-6G + neutrophils among CD45 + leukocytes (one-way ANOVA with Bonferroni’s correction). (F-G) Immunofluorescence visualization (200×, 50 μm scale) and ImageJ quantification of Ly-6G + CD11b + cell infiltrate in 5 high-power fields (HPF). n = 5 mice/group. Data are expressed as mean ± SD. ns: not significant, *** P < 0.001.

Article Snippet: Reagents included AOM and SB225002 (Sigma, St. Louis, USA), DSS (MP Biomedicals, Solon, USA), CEBPB siRNA from Thermo Fisher (Grand Island, USA) (Supplementary Table S7), and a pcDNA3.1- CEBPB plasmid (Real Gene, Nanjing, China).

Techniques: Dissection, Microscopy, Staining, Flow Cytometry, Immunofluorescence

CEBPB affects the progression of UCCRC mice: (a) the modeling method of AOM/DSS-induced UCCRC in mice and treatment regimens, (b) representative photographs of AOM/DSS-induced UCCRC in mice, (c) colorectal length of mice, (d) colon weight of mice, (e) survival rate of mice, and (f) body weight of mice. N = 10, * P < 0.05.

Journal: Open Life Sciences

Article Title: CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway

doi: 10.1515/biol-2022-1012

Figure Lengend Snippet: CEBPB affects the progression of UCCRC mice: (a) the modeling method of AOM/DSS-induced UCCRC in mice and treatment regimens, (b) representative photographs of AOM/DSS-induced UCCRC in mice, (c) colorectal length of mice, (d) colon weight of mice, (e) survival rate of mice, and (f) body weight of mice. N = 10, * P < 0.05.

Article Snippet: Recombinant adeno-associated virus serotype 9 (rAAV9) expressing a siRNA targeting CEBPB (siCEBPB), full-length CEBPB cDNA (CEBPB), and scramble control (NC) were generated by Biowit Technologies Co., Ltd. (Shenzhen, China), according to the manufacturer’s protocol.

Techniques:

CEBPB affects the pathogenic alterations and inflammatory response in UCCRC mice, and representative images of H&E-stained colorectal tissues of mice. The scale bar is 200 μm (a); the concentrations of TNF-α (b), IL-6 (c), and IL-1β (d) in mice’s sera were determined with ELISA kits; the expression of TNF-α (e), IL-6 (f), and IL-1β (g) in colon tissues was determined with RT-qPCR assay, as per the manufacturer’s protocol. * P < 0.05. The red arrows represent the pathological changes.

Journal: Open Life Sciences

Article Title: CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway

doi: 10.1515/biol-2022-1012

Figure Lengend Snippet: CEBPB affects the pathogenic alterations and inflammatory response in UCCRC mice, and representative images of H&E-stained colorectal tissues of mice. The scale bar is 200 μm (a); the concentrations of TNF-α (b), IL-6 (c), and IL-1β (d) in mice’s sera were determined with ELISA kits; the expression of TNF-α (e), IL-6 (f), and IL-1β (g) in colon tissues was determined with RT-qPCR assay, as per the manufacturer’s protocol. * P < 0.05. The red arrows represent the pathological changes.

Article Snippet: Recombinant adeno-associated virus serotype 9 (rAAV9) expressing a siRNA targeting CEBPB (siCEBPB), full-length CEBPB cDNA (CEBPB), and scramble control (NC) were generated by Biowit Technologies Co., Ltd. (Shenzhen, China), according to the manufacturer’s protocol.

Techniques: Staining, Enzyme-linked Immunosorbent Assay, Expressing, Quantitative RT-PCR

CEBPB alters the expression of the related proteins and the activation of NF-κB/STAT3 signaling pathway, IHC analysis of the protein expression of E-cadherin (a) and Ki67 (b) in the UCCRC tissues of mice. The scale bar is 50 μm and 100 μm. (c)–(g) Western blot analysis of the protein expression of Ki67, E-cadherin, N-cadherin, and vimtein in the UCCRC tissues of mice. RT-qPCR analysis of the mRNA expression of Ki67 (h), E-cadherin (i), N-cadherin (j), and vimentin (k) in UCCRC tissues of mice. (l) Western blot analysis of p-STAT3 and NF-κB-p65 expression UCCRC tissues of mice. (m) Western blot analysis of p-STAT3 expression in SW480 cells treatment with PMA. After PMA or Colivelin TFA treats SW480 cells, clone formation, transwell, and scratch-wound assay were used to detect cell proliferation (n), invasion (o), and migration (p). N = 3, * P < 0.05. PMA, phorbol 12-myristate 13-acetate; the red arrows represent the pathological changes.

Journal: Open Life Sciences

Article Title: CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway

doi: 10.1515/biol-2022-1012

Figure Lengend Snippet: CEBPB alters the expression of the related proteins and the activation of NF-κB/STAT3 signaling pathway, IHC analysis of the protein expression of E-cadherin (a) and Ki67 (b) in the UCCRC tissues of mice. The scale bar is 50 μm and 100 μm. (c)–(g) Western blot analysis of the protein expression of Ki67, E-cadherin, N-cadherin, and vimtein in the UCCRC tissues of mice. RT-qPCR analysis of the mRNA expression of Ki67 (h), E-cadherin (i), N-cadherin (j), and vimentin (k) in UCCRC tissues of mice. (l) Western blot analysis of p-STAT3 and NF-κB-p65 expression UCCRC tissues of mice. (m) Western blot analysis of p-STAT3 expression in SW480 cells treatment with PMA. After PMA or Colivelin TFA treats SW480 cells, clone formation, transwell, and scratch-wound assay were used to detect cell proliferation (n), invasion (o), and migration (p). N = 3, * P < 0.05. PMA, phorbol 12-myristate 13-acetate; the red arrows represent the pathological changes.

Article Snippet: Recombinant adeno-associated virus serotype 9 (rAAV9) expressing a siRNA targeting CEBPB (siCEBPB), full-length CEBPB cDNA (CEBPB), and scramble control (NC) were generated by Biowit Technologies Co., Ltd. (Shenzhen, China), according to the manufacturer’s protocol.

Techniques: Expressing, Activation Assay, Western Blot, Quantitative RT-PCR, Scratch Wound Assay Assay, Migration

CEBPB activates the NF-κB/STAT3 signaling pathway in UCCRC mice: (a) Western blot analysis of the protein expression of NF-κB-p65 and p-STAT3 in the UCCRC tissues of mice. (b) Representative photographs of the different groups in mice and (c) the colon weight of mice, (d) colorectal length of mice, and (e) the survival rate of mice. (f) Representative images of H&E-stained colorectal tissues of mice. The scale bar is 200 μm. (g) The concentrations of TNF-α, IL-6, and IL-1β in mice’s sera were determined with ELISA kits. (h) The expression of TNF-α, IL-6, and IL-1β in colon tissues was determined with RT-qPCR assay, as per the manufacturer’s protocol. * P < 0.05. The red arrows represent the pathological changes.

Journal: Open Life Sciences

Article Title: CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway

doi: 10.1515/biol-2022-1012

Figure Lengend Snippet: CEBPB activates the NF-κB/STAT3 signaling pathway in UCCRC mice: (a) Western blot analysis of the protein expression of NF-κB-p65 and p-STAT3 in the UCCRC tissues of mice. (b) Representative photographs of the different groups in mice and (c) the colon weight of mice, (d) colorectal length of mice, and (e) the survival rate of mice. (f) Representative images of H&E-stained colorectal tissues of mice. The scale bar is 200 μm. (g) The concentrations of TNF-α, IL-6, and IL-1β in mice’s sera were determined with ELISA kits. (h) The expression of TNF-α, IL-6, and IL-1β in colon tissues was determined with RT-qPCR assay, as per the manufacturer’s protocol. * P < 0.05. The red arrows represent the pathological changes.

Article Snippet: Recombinant adeno-associated virus serotype 9 (rAAV9) expressing a siRNA targeting CEBPB (siCEBPB), full-length CEBPB cDNA (CEBPB), and scramble control (NC) were generated by Biowit Technologies Co., Ltd. (Shenzhen, China), according to the manufacturer’s protocol.

Techniques: Western Blot, Expressing, Staining, Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR

CEBPB regulates the expression of proteins via activating NF-κB/STAT3 signaling pathway, IHC analysis of the protein expression of E-cadherin and Ki67 in the UCCRC tissues of mice. The scale bar is 50 μm. (b) Western blot analysis of the protein expression of Ki67, E-cadherin, N-cadherin, and vimentin in the UCCRC tissues of mice. (c) Real-time RT-qPCR analysis of the mRNA expression of Ki67, E-cadherin, N-cadherin, and vimentin in colon tissues of mice. N = 3, * P < 0.05. The red arrows represent the pathological changes.

Journal: Open Life Sciences

Article Title: CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway

doi: 10.1515/biol-2022-1012

Figure Lengend Snippet: CEBPB regulates the expression of proteins via activating NF-κB/STAT3 signaling pathway, IHC analysis of the protein expression of E-cadherin and Ki67 in the UCCRC tissues of mice. The scale bar is 50 μm. (b) Western blot analysis of the protein expression of Ki67, E-cadherin, N-cadherin, and vimentin in the UCCRC tissues of mice. (c) Real-time RT-qPCR analysis of the mRNA expression of Ki67, E-cadherin, N-cadherin, and vimentin in colon tissues of mice. N = 3, * P < 0.05. The red arrows represent the pathological changes.

Article Snippet: Recombinant adeno-associated virus serotype 9 (rAAV9) expressing a siRNA targeting CEBPB (siCEBPB), full-length CEBPB cDNA (CEBPB), and scramble control (NC) were generated by Biowit Technologies Co., Ltd. (Shenzhen, China), according to the manufacturer’s protocol.

Techniques: Expressing, Western Blot, Quantitative RT-PCR